• 443
    0

    Two cancer researchers have been awarded the 2018 Nobel Prize in Physiology or Medicine for their discovery of how the immune system can be harnessed to attack tumor cells, which led to immune checkpoint inhibitor therapy. Award has been shared for James P. Allison, PhD, of the University of Texas MD Anderson Cancer Center in ...
  • 477
    0

    Human papillomavirus (HPV) which is familiar with its effects i,e. cancers in women and men, Research around the world has shown a positiveness towards HPV vaccines. Recently British Journal of Clinical Pharmacology has produced a review regarding the post-licensure data and it was notified as “Bivalent HPV vaccine is used in more than 134 countries around the world. This ...
  • 331
    0

    Immunotherapy is a new kind of approach to treat cancer which works to harness the innate powers of the immune system and makes to fight against various diseases. This therapy is most efficient when compared to that of remaining therapies. Because it is based on targeted for systemic treatment and it has fewer side effects,When we compare this immunotherapy with that of chemotherapy . but immunotherapy does not have an ...
  • 580
    0

    U.S. FDA approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer and the second ...
  • 514
    0

    Cancer is a state which involves an abnormal increase in the number of cells, with a potentiality to invade or spread to other parts of the body and destroy their function. Every individual is born with an immune system that acts as a security checkpoint. The immune system does possess B and T lymphocytes, B ...